#covid19 – European Commission boosts urgently needed research and innovation with additional €122 million

The Commission has mobilised another €122 million from its research and innovation programme, Horizon 2020, for urgently needed research into the coronavirus. The new call for expressions of interest contributes to the Commission’s €1.4 billion pledge to the Coronavirus Global Response initiative, launched by President Ursula von der Leyen on 4 May 2020.

The new call is the latest addition to a range of EU-funded research and innovation actions to fight the coronavirus. It complements earlier actions to develop diagnostics, treatments and vaccines by strengthening capacity to manufacture and deploying readily available solutions in order to rapidly address the pressing needs. It will also improve understanding of the behavioural and socio-economic impacts of the epidemic.

The projects funded under this call should repurpose manufacturing for rapid production of vital medical supplies and equipment needed for testing, treatment and prevention, as well as develop medical technologies and digital tools to improve detection, surveillance and patients care.

The deadline for submission is 11 June 2020

This new special call under Horizon 2020 complements earlier actions to support 18 projects with €48.2 million to develop diagnostics, treatments, vaccines and preparedness for epidemics, as well as the €117 million invested in 8 projects on diagnostics and treatments through the Innovative Medicines Initiative, and measures to support innovative ideas through the European Innovation Council.

The new call will cover five areas with the following indicative budgets:

  • Repurposing of manufacturing for vital medical supplies and equipment (€23 million)
  • Medical technologies, Digital tools and Artificial Intelligence analytics to improve surveillance and care at high Technology Readiness Levels (€56 million)
  • Behavioural, social and economic impacts of the outbreak responses (€20 million)
  • Pan-European COVID-19 cohorts (€20 million)
  • Collaboration of existing EU and international cohorts of relevance to COVID-19 (€3 million)

 

 

Source: European Commission press release

 

Services

Categories

Tags